Table 1.
Demographic characteristics of respondents. Data were statistically significant at P < 0.05 compared with control
| Measurements | Control (n = 115) Mean ± SD |
Propofol (n = 115) Mean ± SD |
Metoclopramide (n = 115) Mean ± SD |
P Value |
|---|---|---|---|---|
| Age (years) | 31.17 ± 5.12 | 33.33 ± 5.28 | 31.33 ± 5.35 | 0.73 (NS) |
| Weight (kg) | 64.50 ± 7.23 | 64.83 ± 6.49 | 65.00 ± 7.10 | 0.92 (NS) |
| BMI | 29.17 ± 3.49 | 30.50 ± 3.08 | 29.67 ± 3.27 | 0.78 (NS) |
| Primip parity | 42.00 ± 0.58 | 42.00 ± 1.00 | 42.33 ± 1.53 | 0.91 (NS) |
| Multiparity | 67.68 ± 0.58 | 67.00 ± 1.00 | 67.68 ± 0.58 | 0.49 (NS) |
| Grand Multiparity | 5.67 ± 0.58 | 6.00 ± 0.00 | 6.00 ± 1.73 | 0.91 (NS) |
| Gestational age (weeks) | 39.17 ± 1.72 | 38.83 ± 1.17 | 39.67 ± 1.37 | 0.61 (NS) |
BMI Basal metabolic index, n Number of respondents included in the analysis, SD Standard deviation, NS No significant